HIV initiates its infectious cycle by docking to CD4 and a chemokine receptor, most commonly CCR5. RANTES, a natural CCR5 ligand, is a potent inhibitor of HIV-1. Despite the lack of structural information on the RANTES-CCR5 complex, determinants of HIV blockade were previously identified within the RANTES N-loop and β1-strand regions. A prototype N-loop/β1-strand peptide, named R11-29, contains two terminal hydrophobic stretches separated by a central hydrophilic region. Here, the role of the terminal hydrophobic clusters was investigated by means of amino acid substitutions or deletions. Most hydrophobic residues in these clusters were shown to be fundamental for the anti-HIV activity. However, increasing the hydrophobicity of the two clus...
RANTES (CCL5) is a chemokine that recruits immune cells to inflammatory sites by interacting with th...
medecine.unige.ch The HIV coreceptor CCR5 is a validated target for both the prevention and therapy ...
medecine.unige.ch The HIV coreceptor CCR5 is a validated target for both the prevention and therapy ...
HIV initiates its infectious cycle by docking to CD4 and a chemokine receptor, most commonly CCR5. R...
HIV initiates its infectious cycle by docking to CD4 and a chemokine receptor, most commonly CCR5. R...
HIV initiates its infectious cycle by docking to CD4 and a chemokine receptor, most commonly CCR5. R...
CCR5, the major HIV-1 coreceptor, is a primary target for HIV-1 entry inhibition strategies. CCL5/RA...
SummaryCCR5, the major HIV-1 coreceptor, is a primary target for HIV-1 entry inhibition strategies. ...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
Although selected chemokines act as natural inhibitors of human immunodeficiency virus (HIV) infecti...
The HIV coreceptor CCR5 is a validated target for both the prevention and therapy of HIV infection. ...
RANTES (CCL5) is a chemokine that recruits immune cells to inflammatory sites by interacting with th...
medecine.unige.ch The HIV coreceptor CCR5 is a validated target for both the prevention and therapy ...
medecine.unige.ch The HIV coreceptor CCR5 is a validated target for both the prevention and therapy ...
HIV initiates its infectious cycle by docking to CD4 and a chemokine receptor, most commonly CCR5. R...
HIV initiates its infectious cycle by docking to CD4 and a chemokine receptor, most commonly CCR5. R...
HIV initiates its infectious cycle by docking to CD4 and a chemokine receptor, most commonly CCR5. R...
CCR5, the major HIV-1 coreceptor, is a primary target for HIV-1 entry inhibition strategies. CCL5/RA...
SummaryCCR5, the major HIV-1 coreceptor, is a primary target for HIV-1 entry inhibition strategies. ...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
The chemokine receptor CCR5 is utilized as a critical coreceptor by most primary HIV-1 strains. Whil...
Although selected chemokines act as natural inhibitors of human immunodeficiency virus (HIV) infecti...
The HIV coreceptor CCR5 is a validated target for both the prevention and therapy of HIV infection. ...
RANTES (CCL5) is a chemokine that recruits immune cells to inflammatory sites by interacting with th...
medecine.unige.ch The HIV coreceptor CCR5 is a validated target for both the prevention and therapy ...
medecine.unige.ch The HIV coreceptor CCR5 is a validated target for both the prevention and therapy ...